Related Experiment Video

Updated: May 5, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

28.2K

Universal Cardiovascular Disease Risk Assessment in Pregnancy: Call to Action JACC: Advances Expert Panel

Afshan B Hameed1, Maryam Tarsa2, Cornelia R Graves3

  • 1Maternal-Fetal Medicine, Obstetrics & Gynecology, Cardiology, University of California, Irvine, California, USA.

JACC. Advances
|October 7, 2024
PubMed

Insights

Implementing universal cardiovascular disease (CVD) risk assessment in pregnant and postpartum patients can improve early diagnosis and reduce maternal deaths. This strategy enhances awareness and facilitates timely interventions for better maternal health outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Maternal Health
  • Public Health

Background:

  • The US faces high maternal mortality, with cardiovascular disease (CVD) as a leading cause.
  • Diagnosing CVD in pregnancy is difficult due to overlapping symptoms with normal pregnancy.
  • Delayed CVD diagnosis in pregnant individuals leads to missed intervention opportunities.

Purpose of the Study:

  • To advocate for universal cardiovascular disease (CVD) risk assessment in pregnant and postpartum patients.
  • To highlight the importance of early CVD diagnosis for improving maternal outcomes.
  • To promote the integration of validated CVD risk assessment tools into routine obstetric care.

Main Methods:

  • Implementing universal CVD risk assessment across clinical settings for pregnant and postpartum patients.
  • Integrating validated risk assessment tools into routine obstetric care.
  • Enhancing clinician awareness of cardiovascular risk through education and screening.

Main Results:

  • Potential for enhanced awareness of cardiovascular risk among healthcare providers.
  • Facilitation of earlier CVD diagnosis in pregnant and postpartum individuals.
  • Opportunity for timely intervention to improve maternal health outcomes.

Conclusions:

  • Universal CVD risk assessment is a pivotal strategy to address maternal mortality.
  • Integrating risk assessment tools can improve early CVD detection and intervention.
  • This approach can advance maternal healthcare equity and reduce CVD-related deaths.

Keywords:
cardio-obstetricscardiovascular diseasehigh-risk pregnancypregnancyuniversal CVD risk assessment

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

11.5K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891